Drug profile · INN
necitumumab
PORTRAZZA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
necitumumab (PORTRAZZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intra-articular, intramuscular, intravitreal. Current US regulatory status: approved.
Key facts
INN necitumumab
Brand PORTRAZZA
Route INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
Formulation INJECTABLE
ATC code L01
Frequently asked questions
What is necitumumab?
necitumumab (PORTRAZZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intra-articular, intramuscular, intravitreal. Current US regulatory status: approved.
What is the brand name for necitumumab?
PORTRAZZA is a marketed brand name for necitumumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of necitumumab?
necitumumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.